Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Verge Genomics logo

Verge Genomics

Recent Finacing

Series B

Recent Raise

$98M

Verge Genomics uses an AI-driven drug discovery platform applying machine learning to proprietary human brain genomics datasets to identify and develop therapeutics for neurodegenerative diseases, advancing internal small-molecule programs.

Founded 2015
California, United States
11-50
Private
vergegenomics.com

Highlights

Focus Areas

Biotechnology
Genetics
Health Care
Machine Learning
Neuroscience

Recent Investors

Eli Lilly and Company logo
ALS Investment Fund logo
Tao Capital Partners logo
Merck logo
Threshold Ventures logo
BlackRock logo
Vulcan Capital logo
LifeForce Capital logo
Section 32 logo
WuXi AppTec logo
DFJ logo
OS Fund logo

Financials

$159M

Total Raised

4

Funding rounds

19

Investors


Team

Upgrade to view the team

See the team members at Verge Genomics.